Home Newsfeeds HC Wainwright & Co. Downgrades ObsEva to Neutral

HC Wainwright & Co. Downgrades ObsEva to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades ObsEva (NASDAQ:OBSV) from Buy to Neutral.

byBenzinga Newsdesk

August 30, 2022

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades ObsEva (NASDAQ:OBSV) from Buy to Neutral.

Would You Eat Woolly Mammoth Meat? You Might Have The Chance Soon

By Chris Katje

March 30, 12:55 PM

An extinct mammal from thousands of years ago is the subject of a new food item that could find its way to market. Here’s the crazy strange tale of Woolly Mammoth meatballs.

BYND

Syra Health Secures Statewide Healthcare Contract In Missouri

By Benzinga Newsdesk

March 28, 8:11 AM

Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today it has secured a healthcare workforce

SYRA

Bitcoin Edges Lower Following Jobs Data; Pepe Emerges As Top Gainer

By Lisa Levin

May 5, 9:31 AM

Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices below the $29,000 level on Friday. Ethereum (CRYPTO: ETH) also edged lower, trading close to the key $1,900 mark this morning.

$FLOKI

Similarweb Sees Q3 Sales $48.8M-$49.2M vs $50.5M Est., Sees FY22 Sales $196M-$197M vs $196.55M Est.

By Bill Haddad

August 9, 5:23 PM

Financial Outlook "We are pleased with our results," said Jason Schwartz, Chief Financial Officer of Similarweb. "Our disciplined execution in this challenging environment of rising global

SMWB

HC Wainwright & Co. Downgrades ObsEva to Neutral

Related Posts

Would You Eat Woolly Mammoth Meat? You Might Have The Chance Soon

Syra Health Secures Statewide Healthcare Contract In Missouri

Bitcoin Edges Lower Following Jobs Data; Pepe Emerges As Top Gainer

Similarweb Sees Q3 Sales $48.8M-$49.2M vs $50.5M Est., Sees FY22 Sales $196M-$197M vs $196.55M Est.